Subgroup analysis revealed that the severity of CAD did not correlate with neither DHA nor EPA concentrations in blood in patients with lower AMPKα2 levels (AMPKα2 < 8.2 pg/mL, n = 135) (Fig. 7D, E). Here, PRKAA2 is linked to coronary artery disorder.